Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The World Health Organization has recommended updated treatment protocols to combat drug-resistant gonorrhea, chlamydia and syphilis.
The main goal of HIV treatment is to fully suppress the virus so that your routine viral load tests consistently come back undetectable.
Those with surpassed HIV who cut back on taking Atripla from daily to 3 times a week maintained an undetectable viral load for 6 months.
Levels of transmitted antiretroviral resistance are high among the HIV population in Washington, DC, but have fallen in recent years.
People treated for HIV in Switzerland have seen steadily falling rates of resistance to antiretrovirals (ARVs) since 1999.
Among people who fail HIV treatment, resistance to tenofovir is common, and the incidence of such acquired resistance is likely increasing.
Those who develop resistance to Truvada after contracting HIV shortly before or while taking PrEP do not maintain such resistance for long.
ViiV Healthcare’s integrase inhibitor Tivicay (dolutegravir) effectively fights HIV even when people have taken HIV meds before and have resis...
The Scripps Research Institute will get $20 million over five years from the NIH to study how drug resistance develops in HIV.
When it comes to treating gonorrhea, the U.S. Centers for Disease Control and Prevention (CDC) are now down to “last resort” efforts to...
New data suggest about two in 10 individuals diagnosed with HIV in recent years were infected with HIV strains harboring mutations.
The last line of defense against gonorrhea is losing its effectiveness against the gonorrhea, according to a new article published...
Merck’s integrase inhibitor Isentress (raltegravir) continues to perform well, compared with Sustiva (efavirenz), after four years in people l...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.